Business development and management consultancy for the life sciences sector

Left content image

A broad and extensive range of expertise for
life science companies and institutes including:

  • Strategic partnering
  • Due
    diligence
  • Valuation
  • Intellectual property
  • Commercial negotiation

Small companies often do not have all the in-house expertise they need. Our experience includes identifying and valuing both in and out partnering opportunities, due diligence, devising and delivering on business and development strategy, commercial and legal negotiations and intellectual property strategy and prosecution.

We can also cover the areas of finance, HR and IT. We are happy to discuss any assignment from a review of an invention to determining potential commercial value, business planning through to project or interim management to NED positions.

Our experience

  • Several partnering deals for antibody drug conjugate technology with a biodollar value in excess of $500m and including royalties.
  • Composite humanised antibody deals for over $100m biodollar value and with royalties.
  • Securing seed, first and second round funding for Biovex, the oncolytic viral therapy company, which Amgen bought for $1 billion.
  • Commercial due diligence for an IPO.
  • Research collaboration in Cell Therapy Field.
  • Reviewing commercial activity of leading research institute and recommending a rationalisation strategy to optimise financial return.
  • Licensing endoscopic sewing machine patent portfolio to CR Bard, product development and on the market.
  • Commercial due diligence for the purchase of a European speciality pharma company.
  • Company valuation for successful third round funding.
  • Securing Technology Strategy Board and Biomedical Catalyst funding.
  • Interim Technology Transfer Director of King’s College London Business.
  • Interim Head of Medical and Life Sciences for Imperial College Innovations.

Board Positions

  • Executive Director of Stabilitech Ltd
  • Executive Director of Stealthyx Therapeutics Ltd
  • Non-Executive Director of Freemedic plc
  • Non-Executive Director of BioVex
  • Board member of the BioIndustry Association (BIA)

Donna Hackett

Donna Hackett

A highly motivated commercial professional with over 25 years experience in commercialising life science technology through partnering and start-up activity. Scientifically and legally qualified as a non-practising barrister, Donna has a successful track record of wealth creation through deals including partnering of products and technologies and venture financing.

Donna’s previous roles include being an executive team member of Abzena plc as SVP IP Commercial and Legal Affairs where she was responsible for the legal IP and transactional activity, including partnering deals worth over $700m biodollar value plus royalties for antibody and antibody drug conjugate technology; she was COO and executive board member of Stabilitech,ensuring the company was commercially facing, client focussed and using appropriate pricing models when negotiating and concluding agreements for its thermal stabilisation platform. She was also partner of ProPharma Partners, the multi-national commercial and development consulting group; UCL where she headed up the BioPharm Technology Transfer side of UCL Ventures and BTG.

Get in touch

Donna Hackett

Director: KDH BioManagement Limited

+44 (0) 771 423 4705

donnahackett@kdhbio.com

49d St Augustine’s Road, London NW1 9RL, UK